Current and historical daily PE Ratio for SRDX (
Surmodics Inc
) from 1998 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Surmodics stock (SRDX) PE ratio as of Jun 07 2024 is 44.16.
More Details
Surmodics Inc (SRDX) PE Ratio (TTM) Chart
Surmodics Inc (SRDX) PE Ratio (TTM) Historical Data
View and export this data going back to 1998. Start your Free Trial
Total 1245
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Surmodics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | 44.2 | 2024-04-04 | 28.6 |
| 2024-06-06 | 44.2 | 2024-04-03 | 28.4 |
| 2024-06-05 | 44.2 | 2024-04-02 | 28.4 |
| 2024-06-04 | 44.2 | 2024-04-01 | 29.4 |
| 2024-06-03 | 44.3 | 2024-03-28 | 30.9 |
| 2024-05-31 | 44.3 | 2024-03-27 | 75.8 |
| 2024-05-30 | 44.3 | 2024-03-26 | 74.2 |
| 2024-05-29 | 44.3 | 2024-03-25 | 72.2 |
| 2024-05-28 | 37.0 | 2024-03-22 | 72.8 |
| 2024-05-24 | 36.2 | 2024-03-21 | 74.4 |
| 2024-05-23 | 36.0 | 2024-03-20 | 75.8 |
| 2024-05-22 | 37.1 | 2024-03-19 | 73.1 |
| 2024-05-21 | 36.7 | 2024-03-18 | 72.3 |
| 2024-05-20 | 36.9 | 2024-03-15 | 74.1 |
| 2024-05-17 | 36.4 | 2024-03-14 | 74.5 |
| 2024-05-16 | 35.9 | 2024-03-13 | 76.3 |
| 2024-05-15 | 35.3 | 2024-03-12 | 77.3 |
| 2024-05-14 | 34.7 | 2024-03-11 | 77.5 |
| 2024-05-13 | 34.2 | 2024-03-08 | 80.7 |
| 2024-05-10 | 33.9 | 2024-03-07 | 79.3 |
| 2024-05-09 | 34.0 | 2024-03-06 | 78.4 |
| 2024-05-08 | 33.3 | 2024-03-05 | 79.8 |
| 2024-05-07 | 33.5 | 2024-03-04 | 83.3 |
| 2024-05-06 | 34.2 | 2024-03-01 | 84.4 |
| 2024-05-03 | 34.2 | 2024-02-29 | 84.0 |
| 2024-05-02 | 36.4 | 2024-02-28 | 85.7 |
| 2024-05-01 | 35.1 | 2024-02-27 | 87.5 |
| 2024-04-30 | 27.0 | 2024-02-26 | 86.8 |
| 2024-04-29 | 27.2 | 2024-02-23 | 86.3 |
| 2024-04-26 | 27.6 | 2024-02-22 | 83.9 |
| 2024-04-25 | 27.6 | 2024-02-21 | 82.9 |
| 2024-04-24 | 27.4 | 2024-02-20 | 83.1 |
| 2024-04-23 | 28.3 | 2024-02-16 | 82.3 |
| 2024-04-22 | 26.7 | 2024-02-15 | 85.7 |
| 2024-04-19 | 27.9 | 2024-02-14 | 86.9 |
| 2024-04-18 | 27.8 | 2024-02-13 | 84.2 |
| 2024-04-17 | 27.9 | 2024-02-12 | 89.7 |
| 2024-04-16 | 28.0 | 2024-02-09 | 86.1 |
| 2024-04-15 | 27.8 | 2024-02-08 | 83.9 |
| 2024-04-12 | 28.4 | 2024-02-07 | 81.0 |
| 2024-04-11 | 29.1 | 2024-02-06 | 80.9 |
| 2024-04-10 | 29.1 | 2024-02-05 | 80.9 |
| 2024-04-09 | 29.2 | 2024-02-02 | 83.6 |
| 2024-04-08 | 28.9 | 2024-02-01 | 85.3 |
| 2024-04-05 | 28.5 | 2024-01-31 | 92.7 |
Surmodics Inc (SRDX) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Surmodics Inc
NAICS : 325413
SIC : 3845
ISIN : US8688731004
Description
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers